A group of pigmented, slowly growing mycobacteria identified by 16S rRNA gene sequencing as 'MCRO 33' (GenBank accession no. AF152559) have been isolated from several clinical specimens in various laboratories across Canada. Genotypically, the organism is most closely related to Mycobacterium simiae. However, it presents with a similar phenotypic profile to Mycobacterium scrofulaceum. Several reference strains obtained from ATCC and TMC culture collections, previously identified as M. scrofulaceum or M. simiae, have also been found to possess the MCRO 33 16S rRNA gene sequence. Biochemical testing, susceptibility testing, HPLC, hsp65 gene and 16S-23S spacer (ITS1) sequencing were performed on clinical and reference strains to characterize further this unique species. Of the clinical strains, one was isolated from a cervix biopsy whereas all other clinical isolates were obtained from respiratory samples. In one patient, symptoms, imaging and repeat clinical specimens positive on culture for this organism were suggestive of active clinical disease. The description of this species, for which the name Mycobacterium parascrofulaceum sp. nov. is proposed, follows the present trend of a large number of novel Mycobacterium species identified due in great part to sequence-based methods. The type strain is HSC68 T (=ATCC BAA-614 T =DSM 44648 T ).
INTRODUCTIONSequence-based identification of non-tuberculous mycobacteria (NTM) has become a method of choice in several mycobacteriology laboratories and is accomplished by analysis of various targets, such as the 16S rRNA gene, 16S-23S spacer region (ITS1) and hsp65 gene. As a result, we are faced with the discovery of many novel species previously undifferentiable using other methods of identification. These cannot be ignored, since current studies show that the detection of novel species is a common occurrence that will only be compounded with an increase in use of automated sequencers in clinical laboratories, with some of these unusual isolates deemed clinically significant (Tortoli et al., 2001). The purpose of this study was to establish as a novel species a group of representative mycobacterial strains commonly found, not only in human clinical isolates obtained from our laboratory, but also in several past publications where evidence of its existence has been found. This species has shown similarities to several known NTM species using single identification methods, which may have been the cause for the delay in its establishment, but it is clearly a unique species as determined from a polyphasic approach. In one symptomatic patient, this organism was isolated in multiple respiratory samples, and associated computed tomography (CT) scan and chest X-ray showed evidence of respiratory disease, as described below.